LINC02414

Across TCGA pan-cancer cohorts, LINC02414 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated LINC02414 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher LINC02414 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02414 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

THCA, KIRC, and KIRP are the cancer types where LINC02414 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.563	0.927	<.001	75	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
KIRP	DFS	Tertile	III,IV	0.191	0.720	.003	18	view →
OV	DFS	Tertile	All	0.356	0.152	.033	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

LINC02414–THCA (OS)

Open the THCA breakdown →